This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
14 Aug 2019

Delivering complete aseptic vial handling solutions

Bringing freeze drying and vial washing/sterilizing technologies together with advanced and comprehensive vial and syringe filling capabilities.

SP Scientific has signed a new partnership agreement with Lab-i-DOSiTECNO Pharma Technologies enabling both companies to offer complete aseptic vial and syringe fill-finish lines lines for injectable, ophthalmic and oral products in liquid and powder form.

This new global partnership brings together best-in-class freeze drying and vial washing/sterilizing technologies from SP Scientific with the advanced and comprehensive vial and syringe filling capabilities of Lab-i-DOSiTECNO.

Oriol Casòliva, CEO of Lab-i-DOSiTECNO commented: “The geographic synergies of SP Scientific and Lab-iDosiTECNO working together will enable us to provide outstanding local support throughout North America and Europe, significantly broadening the reach of both partners.”

Brian Larkin, CEO of SP Scientific added: “In addition, for those who prefer to work with a single supplier for full lines, this new partnership enables us to provide and support these customers with top quality, highly productive aseptic fill-finish line solutions."

Biopharmaceutical products are often frozen and then thawed, freeze-dried to be rehydrated when needed, or encapsulated in liquid form without being touched by the atmosphere. The container that holds the medicine during transportation through a variety of global climates, and how it is filled, is therefore critical to product integrity. SP Scientific, in partnership with Lab-i-DOSiTECNO, now leads the way in the development and manufacture of complete aseptic vial fill-finish lines offering the broadest lyophilization range available today covering cycle development, stability, pilot and clinical batch production, through to full aseptic manufacturing and commercial production batches.

Related News